Carson Wealth (CWM LLC)
AMLX icon

Carson Wealth (CWM LLC)’s Amylyx Pharmaceuticals AMLX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.6K Buy
1,263
+70
+6% +$985 ﹤0.01% 4492
2025
Q4 		$14K Buy
1,193
+7
+0.6% +$95 ﹤0.01% 4350
2025
Q3 		$16K Buy
1,186
+296
+33% +$2.79K ﹤0.01% 4239
2025
Q2 		$6K Hold
890
– – ﹤0.01% 4515
2025
Q1 		$3K Hold
890
– – ﹤0.01% 4596
2024
Q4 		$3K Hold
890
– – ﹤0.01% 4377
2024
Q3 		$3K Sell
890
-27,753
-97% -$62.4K ﹤0.01% 4237
2024
Q2 		$54K Buy
28,643
+14,613
+104% +$28.3K ﹤0.01% 2425
2024
Q1 		$40K Buy
14,030
+827
+6% +$10.8K ﹤0.01% 2440
2023
Q4 		$194K Buy
13,203
+34
+0.3% +$521 ﹤0.01% 1438
2023
Q3 		$241K Hold
13,169
– – ﹤0.01% 1234
2023
Q2 		$284K Buy
13,169
+10,512
+396% +$284K ﹤0.01% 1130
2023
Q1 		$78K Buy
+2,657
New +$92.3K ﹤0.01% 1618

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Carson Wealth (CWM LLC)'s AMLX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Amylyx Pharmaceuticals (AMLX) stake by 5.9% in Q1 2026, buying an estimated $985 and bringing the position to 1,263 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4492.

Carson Wealth (CWM LLC) first reported a position in AMLX in Q1 2023 and has held it in 13 quarters since. The position peaked at $284K in Q2 2023. 171 funds tracked by Wall St. Rank hold AMLX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,263 shares of Amylyx Pharmaceuticals worth $17.6K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 70 Amylyx Pharmaceuticals shares in Q1 2026, an estimated $985.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4492 holding.
  • Carson Wealth (CWM LLC) first reported a position in Amylyx Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
  • Carson Wealth (CWM LLC)'s Amylyx Pharmaceuticals position peaked at $284K in Q2 2023.
  • 171 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.